Company news

Neurizon Therapeutics Limited news in 2018

Neurizon Therapeutics Limited's news releases, calls and decks from 2018, newest first.

View company

PharmAust Develops Method for MPL/Analogue Manufacture

December 2, 2018

GMP Tablet Manufacture Commences for Canine Clinical Trials

November 12, 2018

Appendix 4C & Company Update - Sep 2018

October 31, 2018

PharmAust Develops GMP Method for Monepantel Analogues

October 28, 2018

PharmAust Progresses Monepantel Tablet Program for Cancer

October 14, 2018

Olivia Newton-John Cancer Reseach Institute collaboration

September 10, 2018

Reformulation of MPL into tablet form for upcoming trials

September 3, 2018

Appendix 4C & Company Update - June 18

July 31, 2018

Epichem gains prestigious international ISO accreditation

July 1, 2018

Epichem Awarded Major US Drug Discovery Contract Extension

June 6, 2018

MPL successfully reformulated for canine clinical trials

May 27, 2018

Chief Executive Officer resigns

May 21, 2018

Appendix 4C & Company Update

April 30, 2018

PharmAust enters option to license agreement with Elanco

April 18, 2018

Appendix 4D and Half Yearly Report & Accounts

February 28, 2018

PharmAust receives $354k R&D Tax Incentive Refund

February 27, 2018

Appendix 4C - Quarterly Report & Shareholders Update

January 30, 2018

Monepantel reformulation successfully improves dose & taste

January 29, 2018

Epichem Awarded One Year Contract Extension from DNDi

January 17, 2018

Decks in 2018